Reference
Thakore NJ, et al. A Cost-Effectiveness Framework for Amyotrophic Lateral Sclerosis, Applied to Riluzole. Value in Health : 9 Oct 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.06.012
Rights and permissions
About this article
Cite this article
Updated estimate of the cost effectiveness of riluzole for ALS in the US. PharmacoEcon Outcomes News 865, 33 (2020). https://doi.org/10.1007/s40274-020-7257-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-7257-8